Will There Be Immune Adjuvants in Swine Flu Vaccines?
The U.S. government has contracts with several drug companies to develop and produce swine flu vaccines. At least two of those companies, Novartis and GlaxoSmithKline, are using an adjuvant in their H1N1 vaccines.
The adjuvant? Squalene.
According to Meryl Nass, M.D., an authority on the anthrax vaccine,
“A novel feature of the two H1N1 vaccines being developed by companies Novartis and GlaxoSmithKline is the addition of squalene-containing adjuvants to boost immunogenicity and dramatically reduce the amount of viral antigen needed. This translates to much faster production of desired vaccine quantities.”[v]
Novartis’s proprietary squalene adjuvant for their H1N1 vaccine is MF59. Glaxo’s is ASO3. MF59 has yet to be approved by the FDA for use in any U.S. vaccine, despite its history of use in other countries.
Per Dr. Nass, there are only three vaccines in existence using an approved squalene adjuvant. None of the three are approved for use in the U.S.
What Squalene Does to Rats
Oil-based vaccination adjuvants like squalene have been proved to generate concentrated, unremitting immune responses over long periods of time.[vi]
A 2000 study published in the American Journal of Pathology demonstrated a single injection of the adjuvant squalene into rats triggered “chronic, immune-mediated joint-specific inflammation,” also known as rheumatoid arthritis.[vii]
The researchers concluded the study raised questions about the role of adjuvants in chronic inflammatory diseases.
When it comes to vaccines just say NO! These vaccines are dangerous, experimental, and UNINSURABLE. The companies have already arranged immunity from prosecution because they know the risks to you and your family. However, for these companies their profit is more important than life itself.
Read the whole article here. http://articles.mercola.com/sites/articles/archive/2009/08/04/Squalene-The-Swine-Flu-Vaccines-Dirty-Little-Secret-Exposed.aspx
No comments:
Post a Comment